Free Trial
NASDAQ:BJDX

Bluejay Diagnostics (BJDX) Stock Price, News & Analysis

Bluejay Diagnostics logo
$1.64 +0.03 (+1.86%)
Closing price 04:00 PM Eastern
Extended Trading
$1.64 0.00 (0.00%)
As of 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bluejay Diagnostics Stock (NASDAQ:BJDX)

Key Stats

Today's Range
$1.61
$1.73
50-Day Range
$1.52
$2.25
52-Week Range
$1.46
$37.50
Volume
50,203 shs
Average Volume
662,535 shs
Market Capitalization
$2.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bluejay Diagnostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
25th Percentile Overall Score

BJDX MarketRank™: 

Bluejay Diagnostics scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Bluejay Diagnostics.

  • Percentage of Shares Shorted

    3.79% of the float of Bluejay Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Bluejay Diagnostics has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bluejay Diagnostics has recently decreased by 34.11%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Bluejay Diagnostics does not currently pay a dividend.

  • Dividend Growth

    Bluejay Diagnostics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.79% of the float of Bluejay Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Bluejay Diagnostics has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bluejay Diagnostics has recently decreased by 34.11%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Bluejay Diagnostics has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Bluejay Diagnostics this week, compared to 0 articles on an average week.
  • Search Interest

    Only 1 people have searched for BJDX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bluejay Diagnostics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.08% of the stock of Bluejay Diagnostics is held by insiders.

  • Percentage Held by Institutions

    Only 18.47% of the stock of Bluejay Diagnostics is held by institutions.

  • Read more about Bluejay Diagnostics' insider trading history.
Receive BJDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bluejay Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

BJDX Stock News Headlines

Bluejay Diagnostics (NASDAQ:BJDX) Trading Up 1.3% - What's Next?
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Bluejay Diagnostics Inc BJDX
Bluejay Diagnostics announces abstract acceptance at 2025 SAEM meeting
See More Headlines

BJDX Stock Analysis - Frequently Asked Questions

Bluejay Diagnostics' stock was trading at $4.87 at the beginning of 2025. Since then, BJDX stock has decreased by 66.3% and is now trading at $1.64.

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) released its quarterly earnings results on Tuesday, May, 13th. The company reported ($3.37) earnings per share (EPS) for the quarter.

Bluejay Diagnostics shares reverse split before market open on Thursday, June 20th 2024.The 1-8 reverse split was announced on Thursday, June 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Bluejay Diagnostics (BJDX) raised $22 million in an initial public offering on Wednesday, November 10th 2021. The company issued 2,160,000 shares at a price of $10.00 per share.

Shares of BJDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bluejay Diagnostics investors own include SoFi Technologies (SOFI), Athenex (ATNX), V.F. (VFC), Allarity Therapeutics (ALLR), Andersons (ANDE) and British American Tobacco (BTI).

Company Calendar

Last Earnings
5/13/2025
Today
7/15/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BJDX
CIK
1704287
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($379.74)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.72 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-322.46%
Return on Assets
-262.96%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.71
Quick Ratio
2.71

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.34 per share
Price / Book
0.16

Miscellaneous

Outstanding Shares
1,494,000
Free Float
1,493,000
Market Cap
$2.46 million
Optionable
Not Optionable
Beta
0.47
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:BJDX) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners